Literature DB >> 19693529

Comparison of cryopreserved and air-dried human amniotic membrane for ophthalmologic applications.

Henning Thomasen1, Mikk Pauklin, Klaus-Peter Steuhl, Daniel Meller.   

Abstract

BACKGROUND: Cryopreserved amniotic membrane (Cryo-AM) is widely used in ocular surface surgery because of its positive effect on wound healing and its anti-inflammatory properties. A new peracetic acid/ethanol sterilized air-dried amniotic membrane (AD-AM) recently became available which might be an alternative to Cryo-AM. Our aim was to compare AM preserved with both methods with regard to the release of wound-healing modulating proteins, the preservation of basement membrane components, and the ability to serve as a substrate for the cultivation of human limbal epithelial cells (HLECs).
METHODS: Pieces of Cryo-AM and AD-AM from three different donors were incubated in DMEM for five days. The culture supernatant was collected after an incubation period of 0.1, 24, 48, 72 and 120 h; in the case of AD-AM, this period was extended up to 14 days. TIMP-1, IL-1ra, CTGF and TGF-beta1 were detected in the culture supernatant using Western blotting. Twenty human limbal epithelial cultures were initiated on both AD- and Cryo-AM. The cultures were analyzed morphologically, and the outgrowth area was measured in 3-day intervals. Cryosections of Cryo- and AD-AM from three different donors were analyzed histochemically to detect the basement membrane components collagen IV, collagen VII, laminin, laminin 5 and fibronectin.
RESULTS: The release of TIMP-1, IL-1ra and TGF-beta1 from Cryo-AM was constant for the studied period. CTGF showed a stronger signal after 120 h. None of the analyzed proteins, except for a small amount of IL-1ra, could be detected in the supernatant of AD-AM. An outgrowth of HLEC was observed in all cultures on Cryo-AM, but in only 30% of cultures on AD-AM. The outgrowth area on Cryo-AM was at all time points significantly higher than on AD-AM (p < 0.0001). Collagen IV, -VII, laminins and fibronectin were detectable in the basement membrane of Cryo-AM, but only collagen IV and fibronectin in AD-AM.
CONCLUSIONS: Cryo-AM is a more suitable substrate for the cultivation of HLECs than AD-AM. The higher outgrowth rate of cultured limbal epithelium, release of intact soluble wound-healing modulating factors and a better preservation of basement membrane components suggest the superiority of Cryo-AM for use in ophthalmology in comparison to AD-AM.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19693529     DOI: 10.1007/s00417-009-1162-y

Source DB:  PubMed          Journal:  Graefes Arch Clin Exp Ophthalmol        ISSN: 0721-832X            Impact factor:   3.117


  62 in total

Review 1.  Ex vivo expansion of limbal epithelial stem cells: amniotic membrane serving as a stem cell niche.

Authors:  Martin Grueterich; Edgar M Espana; Scheffer C G Tseng
Journal:  Surv Ophthalmol       Date:  2003 Nov-Dec       Impact factor: 6.048

2.  The variation in transparency of amniotic membrane used in ocular surface regeneration.

Authors:  C J Connon; J Doutch; B Chen; A Hopkinson; J S Mehta; T Nakamura; S Kinoshita; K M Meek
Journal:  Br J Ophthalmol       Date:  2009-03-19       Impact factor: 4.638

3.  Differential distribution of subchains of the basement membrane components type IV collagen and laminin among the amniotic membrane, cornea, and conjunctiva.

Authors:  K Fukuda; T Chikama; M Nakamura; T Nishida
Journal:  Cornea       Date:  1999-01       Impact factor: 2.651

4.  Profiles of pro-inflammatory cytokines in the serum of rabbits after experimentally induced acute pancreatitis.

Authors:  Maher O Osman; Borbala Gesser; Janne T Mortensen; Kouji Matsushima; Steen L Jensen; Christian G Larsen
Journal:  Cytokine       Date:  2002-01-07       Impact factor: 3.861

5.  Expression of matrix metalloproteinases and tissue inhibitors of metalloproteinases in the mouse uterus during the peri-implantation period.

Authors:  S K Das; S Yano; J Wang; D R Edwards; H Nagase; S K Dey
Journal:  Dev Genet       Date:  1997

6.  Role of connective tissue growth factor in the pathogenesis of diabetic nephropathy.

Authors:  N A Wahab; N Yevdokimova; B S Weston; T Roberts; X J Li; H Brinkman; R M Mason
Journal:  Biochem J       Date:  2001-10-01       Impact factor: 3.857

7.  Amniotic membrane transplantation for persistent epithelial defects with ulceration.

Authors:  S H Lee; S C Tseng
Journal:  Am J Ophthalmol       Date:  1997-03       Impact factor: 5.258

8.  Comparison of intact and denuded amniotic membrane as a substrate for cell-suspension culture of human limbal epithelial cells.

Authors:  Noriko Koizumi; Helen Rigby; Nigel J Fullwood; Satoshi Kawasaki; Hidetoshi Tanioka; Kan Koizumi; Norbert Kociok; Antonia M Joussen; Shigeru Kinoshita
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2006-04-13       Impact factor: 3.117

9.  Modulation of the expression of connective tissue growth factor by alterations of the cytoskeleton.

Authors:  Christian Ott; Dominika Iwanciw; Angela Graness; Klaudia Giehl; Margarete Goppelt-Struebe
Journal:  J Biol Chem       Date:  2003-09-01       Impact factor: 5.157

10.  Human amniotic membrane, like corneal epithelial basement membrane, manifests the alpha5 chain of type IV collagen.

Authors:  Ken-ichi Endo; Takahiro Nakamura; Satoshi Kawasaki; Shigeru Kinoshita
Journal:  Invest Ophthalmol Vis Sci       Date:  2004-06       Impact factor: 4.799

View more
  18 in total

1.  Fresh and cryopreserved amniotic membrane secrete the trefoil factor family peptide 3 that is well known to promote wound healing.

Authors:  Ute Schulze; Ulrike Hampel; Saadettin Sel; Tamme W Goecke; Volker Thäle; Fabian Garreis; Friedrich Paulsen
Journal:  Histochem Cell Biol       Date:  2012-04-03       Impact factor: 4.304

Review 2.  Amniotic membrane transplantation in the human eye.

Authors:  Daniel Meller; Mikk Pauklin; Henning Thomasen; Henrike Westekemper; Klaus-Peter Steuhl
Journal:  Dtsch Arztebl Int       Date:  2011-04-08       Impact factor: 5.594

3.  Amniotic membrane covering promotes healing of cornea epithelium and improves visual acuity after debridement for fungal keratitis.

Authors:  Bo Zeng; Ping Wang; Ling-Juan Xu; Xin-Yu Li; Hong Zhang; Gui-Gang Li
Journal:  Int J Ophthalmol       Date:  2014-10-18       Impact factor: 1.779

Review 4.  The progress in techniques for culturing human limbal epithelial stem cells.

Authors:  Yan Shen; Qihua Le
Journal:  Hum Cell       Date:  2022-10-01       Impact factor: 4.374

Review 5.  Review: corneal epithelial stem cells, their niche and wound healing.

Authors:  Federico Castro-Muñozledo
Journal:  Mol Vis       Date:  2013-07-24       Impact factor: 2.367

Review 6.  Applications of Human Amniotic Membrane for Tissue Engineering.

Authors:  Mathilde Fénelon; Sylvain Catros; Christophe Meyer; Jean-Christophe Fricain; Laurent Obert; Frédéric Auber; Aurélien Louvrier; Florelle Gindraux
Journal:  Membranes (Basel)       Date:  2021-05-25

Review 7.  Use of Placental Membranes for the Treatment of Chronic Diabetic Foot Ulcers.

Authors:  Jonathan N Brantley; Thomas D Verla
Journal:  Adv Wound Care (New Rochelle)       Date:  2015-09-01       Impact factor: 4.730

8.  Optimization of optical and mechanical properties of real architecture for 3-dimensional tissue equivalents: Towards treatment of limbal epithelial stem cell deficiency.

Authors:  Isobel Massie; Alvena K Kureshi; Stefan Schrader; Alex J Shortt; Julie T Daniels
Journal:  Acta Biomater       Date:  2015-06-17       Impact factor: 8.947

9.  Retention of Endogenous Viable Cells Enhances the Anti-Inflammatory Activity of Cryopreserved Amnion.

Authors:  Yi Duan-Arnold; Alexandra Gyurdieva; Amy Johnson; Thomas E Uveges; Douglas A Jacobstein; Alla Danilkovitch
Journal:  Adv Wound Care (New Rochelle)       Date:  2015-09-01       Impact factor: 4.730

10.  Dried human amniotic membrane does not alleviate inflammation and fibrosis in experimental strabismus surgery.

Authors:  Bo Young Chun; Hong Kyun Kim; Jae Pil Shin
Journal:  J Ophthalmol       Date:  2013-06-23       Impact factor: 1.909

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.